PHARMACISTS OPTIMIZING CANCER CARE

LIVE

Serial Number

87328084

Owner

Hematology Oncology Pharmacy Association, Inc.

Attorney

Melissa A. Vallone

First Use Date

Mar 16, 2016

Filing Date

Feb 8, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

PHARMACISTS OPTIMIZING CANCER CARE Trademark

Serial Number: 87328084 • Registration: 5630336

PHARMACISTS OPTIMIZING CANCER CARE is a trademark filed by Hematology Oncology Pharmacy Association, Inc. on February 8, 2017. The trademark is classified under Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently registered and active.

Trademark Classes

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

Hematology Oncology Pharmacy Association, Inc. (3 trademarks)

555 E. Wells St.
Milwaukee, WI 53202

Entity Type: 99

Legal Representation

Attorney of Record

Melissa A. Vallone

4,247 trademarks filed View all →

Trademark Details

Filing Date

February 8, 2017

Registration Date

December 18, 2018

First Use Anywhere

March 16, 2016

First Use in Commerce

March 16, 2016

Published for Opposition

October 2, 2018

Goods & Services

Educational services, namely, conducting educational conferences and providing non-downloadable webinars in the field of hematology and oncology pharmacy for pharmacy practitioners; Educational services, namely, providing training of pharmacy practitioners for certification in the field of hematology and oncology; providing on-line non-downloadable journals in the field of hematology and oncology pharmacy

Association services, namely, supporting pharmacy practitioners and promoting and advancing hematology and oncology pharmacy to optimize the care of individuals affected by cancer

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Dec 22, 2024 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Dec 22, 2024 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 22, 2024 APRE

TEAS SECTION 8 & 15 RECEIVED

Jul 23, 2024 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Dec 18, 2023 REM1

REGISTERED-PRINCIPAL REGISTER

Dec 18, 2018 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 2, 2018 NPUB

PUBLISHED FOR OPPOSITION

Oct 2, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 12, 2018 NONP

ASSIGNED TO LIE

Aug 23, 2018 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 14, 2018 CNSA

EXAMINER'S AMENDMENT ENTERED

Aug 14, 2018 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 14, 2018 GNEN

EXAMINERS AMENDMENT E-MAILED

Aug 14, 2018 GNEA

EXAMINERS AMENDMENT -WRITTEN

Aug 14, 2018 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 16, 2018 GNRN

NON-FINAL ACTION E-MAILED

Jan 16, 2018 GNRT

NON-FINAL ACTION WRITTEN

Jan 16, 2018 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 9, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 8, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 8, 2017 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 16, 2017 GNRN

NON-FINAL ACTION E-MAILED

Jun 16, 2017 GNRT

NON-FINAL ACTION WRITTEN

Jun 16, 2017 CNRT

ASSIGNED TO EXAMINER

May 4, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 13, 2017 NWOS

NEW APPLICATION ENTERED

Feb 13, 2017 NWAP

Related Trademarks

More from this Owner

HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC)

HOPA HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION

More in Same Class

PRICE PP POTTENGER

HAWK EARN

INEXTO

MYEZHR

THE LEVERAGING GENIUS INTENSIVE

HAWK REDEEM